Henry Schein (HSIC) Competitors

Henry Schein (NASDAQ:HSIC) and Cardinal Health (NYSE:CAH) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their community ranking, earnings, institutional ownership, risk, analyst recommendations, media sentiment, profitability, valuation and dividends.

Does the media refer more to HSIC or CAH?

In the previous week, Cardinal Health had 5 more articles in the media than Henry Schein. MarketBeat recorded 10 mentions for Cardinal Health and 5 mentions for Henry Schein. Cardinal Health's average media sentiment score of 1.64 beat Henry Schein's score of 1.08 indicating that Cardinal Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Henry Schein	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cardinal Health	9 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Which has more volatility & risk, HSIC or CAH?

Henry Schein has a beta of 0.9, indicating that its stock price is 10% less volatile than the S&P 500. Comparatively, Cardinal Health has a beta of 0.64, indicating that its stock price is 36% less volatile than the S&P 500.

Does the MarketBeat Community prefer HSIC or CAH?

Cardinal Health received 530 more outperform votes than Henry Schein when rated by MarketBeat users. Likewise, 71.70% of users gave Cardinal Health an outperform vote while only 51.54% of users gave Henry Schein an outperform vote.

Company	Underperform	Outperform
Henry Schein	Outperform Votes 367 51.54%	Underperform Votes 345 48.46%
Cardinal Health	Outperform Votes 897 71.70%	Underperform Votes 354 28.30%

Which has higher valuation & earnings, HSIC or CAH?

Henry Schein has higher earnings, but lower revenue than Cardinal Health. Henry Schein is trading at a lower price-to-earnings ratio than Cardinal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Henry Schein	$12.34B	0.71	$416M	$2.96	23.15
Cardinal Health	$205.01B	0.12	$261M	$2.25	43.78

Do insiders and institutionals hold more shares of HSIC or CAH?

96.6% of Henry Schein shares are owned by institutional investors. Comparatively, 87.2% of Cardinal Health shares are owned by institutional investors. 1.1% of Henry Schein shares are owned by insiders. Comparatively, 0.2% of Cardinal Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Do analysts rate HSIC or CAH?

Henry Schein presently has a consensus price target of $81.73, suggesting a potential upside of 19.29%. Cardinal Health has a consensus price target of $107.57, suggesting a potential upside of 9.20%. Given Henry Schein's higher probable upside, analysts clearly believe Henry Schein is more favorable than Cardinal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Henry Schein	1 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.36
Cardinal Health	1 Sell rating(s)	4 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.50

Is HSIC or CAH more profitable?

Henry Schein has a net margin of 3.12% compared to Cardinal Health's net margin of 0.25%. Henry Schein's return on equity of 13.51% beat Cardinal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Henry Schein	3.12%	13.51%	5.79%
Cardinal Health	0.25%	-54.74%	3.98%

Summary

Henry Schein beats Cardinal Health on 10 of the 18 factors compared between the two stocks.